Fig. 1

FBXL19-AS1 expression in cervical cancer tissues and its regulation on the proliferation and apoptosis of cervical cancer cells. A RT-PCR for detection of FBXL19-AS1 expression in 46 cases of CC tissues and adjacent normal tissues. B RT-PCR detection of FBXL19-AS1 expression in Human healthy cervical cells (HUCEC) and human cervical cancer cells (HeLa, Caski, C-33 A, AV3), **p < 0.01, ***p < 0.001 vs. HUCEC group; C KM plotter (http://kmplot.com/analysis/) was used for the analysis of FBXL-19-AS1 expression in the overall survival of CC patients. D C-33 A and HeLa cells were used for the cell model of FBXL19-AS1 overexpression and downregulation, and RT-PCR was used for detection of FBXL19-AS1 expression. E, F The effect of FBXL19-AS1 on the proliferation of C-33 A and HeLa cells was detected via CCK-8 assay, *p < 0.05, **p < 0.01, ***p < 0.001 vs. NC or si-NC group; G Western blot taken to detect the changes of apoptosis protein after FBXL19-AS1 regulation. ***p < 0.001 (n = 3)